decreased of the current liabilities in the amount of THB 20 million as a result of the repayment of the short-term loan to the financial institutions as well as the decrease of the outstanding Corporate
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
decrease in financial cost was due to the repayment of the entire amount of loans from bank in January 2017. Tax Expenses Tax expenses in 2017 and 2016 were 27.90 million and 22.34 million, respectively or
effectively control finance expense by repayment of short-term borrowings which costs high interest such as factoring and promissory notes. Net Profit and Net Margin For the first quarter of 2018, net profits
Baht 24.46 million, a decrease of 62.93% compared to 2017. Final earnings per share resulted at Baht 1.15. Total Revenues 2018 2017 Change (Million Baht) (Million Baht) (%) Sales 2,020.63 2,147.64 (5.91
of December 31, 2019 The consolidated total assets as of 31 December 2019 decreased by 10% yoy. The decrease was mainly attributable to cash spending on loan repayment as well as investment not only in
zone increased from movement sold to EGR Australia to EGR Europe as delivery country. Gross profit margin decreased 5% duted to sold OEM project that high gross profit margin decrease, gross profit of
total assets as of 31 March 2019 decreased by 9% yoy. The decrease was mainly attributable to cash spending on annual capital expenditure and loan repayment as well as land disposal transaction. However
. Net Profit The Company’s net profit for the 3-month period ended 31 March 2018 and 2019 totaled THB 40.68 and 22.90 million consecutively, a decline by THB 17.78 million or 43.71%. Such decrease is due
revenue in Australian and European zones decrease Baht 27 million and Baht 17 million or 36% and 21%, respectively. The export sales to Australia zone declined because in end of Quarter 1, 2018, the Company